Citation 83390

HOPP,DC: CONWAY,WD: MC LAUGHLIN,JL:. (1999). USING COUNTERCURRENT CHROMATOGRAPHY TO ASSIST IN THE PURIFICATION OF NEW ANNONACEOUS ACETOGENINS FROM ANNONA SQUAMOSA.. 10(6)

Citation Details

TitleUSING COUNTERCURRENT CHROMATOGRAPHY TO ASSIST IN THE PURIFICATION OF NEW ANNONACEOUS ACETOGENINS FROM ANNONA SQUAMOSA.
AuthorsHOPP,DC: CONWAY,WD: MC LAUGHLIN,JL:
Year1999
Volume10
Issue6

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Annona squamosa (ANNONACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
ANNORECTICUIN,(CIS-2-4:TRANS):
None
2
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
3
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
4
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
WEAK ACTIVITY
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
STRONG ACTIVITY
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
STRONG ACTIVITY
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
STRONG ACTIVITY
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
STRONG ACTIVITY
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
STRONG ACTIVITY
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
STRONG ACTIVITY
11
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ANNORECTICUIN,(CIS-2-4:TRANS):
ACTIVE
12Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SQUAMOXINONE C,(CIS-2-4:TRANS):
None
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
STRONG ACTIVITY
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
STRONG ACTIVITY
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
STRONG ACTIVITY
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
STRONG ACTIVITY
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
ACTIVE
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
STRONG ACTIVITY
19
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE C,(CIS-2-4:TRANS):
ACTIVE
20Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SQUAMOXINONE B,(CIS-2-4:TRANS):
None
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
STRONG ACTIVITY
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
STRONG ACTIVITY
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
STRONG ACTIVITY
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
STRONG ACTIVITY
25
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
STRONG ACTIVITY
26
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
STRONG ACTIVITY
27
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SQUAMOXINONE B,(CIS-2-4:TRANS):
ACTIVE
28Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
None
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
STRONG ACTIVITY
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
STRONG ACTIVITY
31
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
ACTIVE
32
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
STRONG ACTIVITY
33
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
STRONG ACTIVITY
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
STRONG ACTIVITY
35
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
ASIMICINONE,(CIS-2-4:TRANS): 9-HYDROXY:
ACTIVE
Show SPARQL Queries (1)